Form 4: SOPHiA GENETICS SA Executive Sells Shares
Insider Transaction (Form 4)
Jurgi Camblong, Executive Chairman and a Director of SOPHiA GENETICS SA, sold 28,500 shares of common stock on August 7, 2026.
Summary
- Open-market sale: disposed of 20,000 Ordinary Shares at $7.23 ($144,540) on August 7, 2026; holds 3,452,822 after (Direct).
- Open-market sale: disposed of 8,500 Ordinary Shares at $7.61 ($64,669) on August 10, 2026; holds 3,444,322 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $209,209 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jurgi Camblong — Director, Officer (Executive Chairman)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-07 | Open-market sale | Ordinary Shares | 20,000 | $7 | $144.5K | 3,452,822 |
| 2026-08-10 | Open-market sale | Ordinary Shares | 8,500 | $8 | $64.7K | 3,444,322 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-07 | Open-market sale (20,000 shares) |
| 2026-08-10 | Open-market sale (8,500 shares) |
Keywords
insider transaction, Form 4, SOPH, SOPHiA GENETICS SA, bearish, Jurgi Camblong
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.